GBLT Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Joachim Senst

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	9.8yrs
Eigendom CEO	36.4%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	6.2yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Joachim Senst's beloning veranderd ten opzichte van GBLT's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2023	n/a	n/a	-€1m
Jun 30 2023	n/a	n/a	-€1m
Mar 31 2023	n/a	n/a	-€178k
Dec 31 2022	n/a	n/a	€173k
Sep 30 2022	n/a	n/a	€104k
Jun 30 2022	n/a	n/a	€121k
Mar 31 2022	n/a	n/a	-€593k
Dec 31 2021	€99k	€94k	-€174k
Sep 30 2021	n/a	n/a	€61k
Jun 30 2021	n/a	n/a	€624k
Mar 31 2021	n/a	n/a	€1m
Dec 31 2020	€98k	€88k	€527k
Sep 30 2020	n/a	n/a	-€25k
Jun 30 2020	n/a	n/a	-€683k
Mar 31 2020	n/a	n/a	-€1m
Dec 31 2019	€87k	€73k	-€1m
Sep 30 2019	n/a	n/a	-€433k
Jun 30 2019	n/a	n/a	€45k
Mar 31 2019	n/a	n/a	-€229k
Dec 31 2018	€78k	€72k	-€4m

Compensatie versus markt: Er zijn onvoldoende gegevens om vast te stellen of de totale vergoeding van Joachim redelijk is in vergelijking met bedrijven van vergelijkbare omvang in de German markt.

Compensatie versus inkomsten: De vergoeding van Joachim is gestegen terwijl het bedrijf verliesgevend is.

CEO

Joachim Senst

9.8yrs

Tenure

€98,848

Compensatie

Dr. Jur. Joachim Thilo Senst has been Chief Executive Officer and Director of GBLT Corp. since August 30, 2014 and serves as its President. He served as Interim Chief Financial Officer at GBLT Corp. since...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Joachim Senst	President	9.8yrs	€98.85k	36.43% € 190.7k
Alfred Schopf	Independent Director	6.2yrs	€5.17k	0.049% € 256.6
John Denham	Independent Director	6.2yrs	€5.17k	0.049% € 256.6

6.2yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van 4G9 wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.2 jaar).

GBLT Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

GBLT Corp., Annual General Meeting, Mar 22, 2024

Insufficient new directors

GBLT Corp., Annual General Meeting, Jul 14, 2022

Insufficient new directors

Insufficient new directors

GBLT Corp., Annual General Meeting, Jan 12, 2021

Recent updates

Common Shares of GBLT Corp. to Be Delisted from the TSX Venture Exchange

An unknown buyers acquired 29.1% stake in GBLT Corp. (TSXV:GBLT) from SWT Beteiligungs AG for CAD 1.3 million.

An unknown buyers acquired 29.1% stake in GBLT Corp. (TSXV:GBLT) from SWT Beteiligungs AG for CAD 1.3 million.

GBLT Corp., Annual General Meeting, Mar 22, 2024

Third quarter 2023 earnings released: EPS: €0 (vs €0 in 3Q 2022)

n unknown buyer signed an agreement to acquire 50% plus 1 interest in Gebäude Technologie Center Gmbh from GBLT Corp (TSXV : GBLT) for €0.03 million.

Second quarter 2023 earnings released: €0.002 loss per share (vs €0.007 profit in 2Q 2022)

Full year 2022 earnings released: EPS: €0.002 (vs €0.002 loss in FY 2021)

Third quarter 2022 earnings released: EPS: €0 (vs €0 in 3Q 2021)

Insufficient new directors

GBLT Corp. Announces Global Expansion of Its Dr. Senst Healthcare Products

Second quarter 2022 earnings released: EPS: €0.007 (vs €0.001 in 2Q 2021)

GBLT Corp., Annual General Meeting, Jul 14, 2022

First quarter 2022 earnings released: EPS: €0 (vs €0.004 in 1Q 2021)

Full year 2021 earnings released: €0.002 loss per share (vs €0.005 profit in FY 2020)

Insufficient new directors

Insufficient new directors

GBLT Corp. (TSXV:GBLT) acquired an unknown majority stake in Gebäude Technologie Center Gmbh.

Second quarter 2021 earnings released: EPS €0.001 (vs €0.005 in 2Q 2020)

First quarter 2021 earnings released: EPS €0.004 (vs €0.002 loss in 1Q 2020)

Full year 2020 earnings released: EPS €0.005 (vs €0.01 loss in FY 2019)

GBLT Corp. Announces Initial EUR 200,000 Order

GBLT Receives Initial Order for its Proprietary Line of Disinfectant Products

GBLT Corp. Receives $2.7 Million Follow-On Order from European Mass Merchandiser for Private Battery Label

GBLT Corp. Expands PPE Suite of Products Under the Dr. Senst Brand

GBLT Corp. Receives USD 4.8 Million Contract with European Mass Merchandiser for Private Battery Label

New 90-day high: €0.24

GBLT Corp. Receives an Order of EUR 1.4 Million for Dr. Senst Branded Thermometers

GBLT Corp. Receives €195,000 in PPE Orders from German Retailers and Announces Launch of Online Strategy for Mobile Energy

New 90-day high: €0.20

GBLT Corp. Signs 700,000 Order with Retailer for Thermometers

GBLT Corp. Adds New Major Retailer to Growing Client List

Third quarter 2020 earnings released: EPS €0.005

Third quarter 2020 earnings released: EPS €0.005

GBLT Corp. Expands Relationship with One of Europe's Largest Drug-Store Retailers to Offer PPE

GBLT Corp. Introduces New Line of Patent-Protected Disinfectant Products

GBLT Corp., Annual General Meeting, Jan 12, 2021

First half earnings released

GBLT Receives €275,000 Order with Office Supply Retailer

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur